13 November 2017
Australian Securities Exchange (ASX) Announcement
- Agreement further validates Sensera’s potential to provide high-value microfabrication services at scale to customers in multiple industries
- Agreement involves amendment to prior delivery schedule which will defer revenue from manufacturing for medical device anchor customer by approximately one quarter
- Sensera’s microfabrication business growth is underpinned by both anchor clients having now transitioned from non-recurring engineering to manufacturing customers
Sensera Limited (ASX: SE1, “Sensera” or “the Company”), a leading designer and manufacturer of end to-end sensor solutions and services for the rapidly-growing Internet of Things (IoT) market, is pleased to announce that its wholly owned US subsidiary Sensera Inc (“Sensera”) has entered into a material 3-year supply agreement with one of its anchor microfabrication customers.
Although the name of the customer and the commercial terms are confidential, Sensera advises that the customer is a NASDAQ-listed medical device company with a market capitalisation in excess of US$8bn. The customer holds market leadership with its first-generation implantable medical device in a growing therapeutic market segment.
This multi-year, multimillion dollar supply agreement embeds Sensera as a key part of the supply chain for a high-value medical device that leads the customer’s product portfolio and underpins the customer’s growth aspirations.